A new study has found that ethnicity doesn’t appear to have any influence on the severity of cognitive impairment in people in the early stages of multiple sclerosis (MS).
Researchers already know...
Headaches are a more common side effect of interferon-beta (IFN-beta) treatment than previously thought, as new study has found.
Published in the Journal of Pain Research, the research analysed data...
The government has released further guidance relating to COVID-19 and has announced it will be sending letters out to 1.5 million people in England deemed most vulnerable due to health conditions....
A new study has found that people who experience a relapse from multiple sclerosis (MS) tend to see a decline in cognitive test scores, and sometimes don’t experience a full recovery.
A team of...
A group of medical advisors for the MS Society, which includes some of the leading neurologists in the UK, have agreed the following joint statement on the COVID-19 coronavirus and MS:
“We have been...
As many as one in six carers for people with multiple sclerosis (MS) are working for more than 90 hours a week, a survey by the MS Society has found.
Out of 549 respondents to the survey, all of whom...
Peginterferon beta-1a has been recommended as a treatment option for relapsing remitting multiple sclerosis (RRMS) by The National Institute for Health and Care Excellence (NICE) for use on the NHS...
A team of researchers has been given more than £5 million of funding to develop new medication to help treat multiple sclerosis (MS).
Pheno Therapeutics aims to build on the work of University of...
People with dysphagia, which is a difficulty in swallowing, may live up to two years longer if they have a feeding tube before the age of 50, a new study has found.
It’s estimated around 30% of...
Progressive cognitive decline for people with multiple sclerosis (MS) may not be as inevitable as once thought, a new 10-year study has found.
The study even found that for some patients, a ‘bouncing...
